Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
To own NANO Nuclear Energy, you need to believe microreactors like KRONOS can move from licensing and prototyping into real deployments, while the company manages losses and heavy investment needs. The AFWERX SBIR Phase I award signals early defense interest, but it does not yet change the core near term catalyst, which remains regulatory progress on KRONOS, or the main risk, which is continued pre revenue status and ongoing operating losses.
Against that backdrop, the NRC’s formal acceptance of the KRONOS construction permit application for the University of Illinois prototype stands out as more directly tied to the near term story. That step initiates environmental and safety reviews that must progress smoothly before commercial defense or data center projects can be meaningful, so it sits at the heart of both the potential upside and the risk of delay.
However, investors should also be aware that if KRONOS licensing or early deployments slip, the path to revenue and earnings could look very different...
Read the full narrative on NANO Nuclear Energy (it's free!)
NANO Nuclear Energy's narrative projects $14.9 million revenue and $1.7 million earnings by 2029. This implies an earnings increase of about $33 million from -$31.3 million today.
Uncover how NANO Nuclear Energy's forecasts yield a $41.40 fair value, a 120% upside to its current price.
While the AFWERX win hints at upside, the most bearish analysts were still only assuming about US$800,000 of revenue by 2029, so if you are comparing that cautious view with the possibility that lengthy NRC licensing for the University of Illinois prototype stretches out, it is worth recognizing how far opinions differ and how this new defense contract might eventually shift those expectations.
Explore 3 other fair value estimates on NANO Nuclear Energy - why the stock might be worth over 2x more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com